A Study on the Use of TanakanĀ® for Recovery of Neurological Impairment Following Ischaemic Stroke


Phase 3 Results

Summary of Purpose

The purpose of this study is to evaluate the effectiveness of TanakanĀ® 240mg in association with Acetylsalicylic acid (325mg/day) in the recovery of neurological impairment following ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 February 2018.

1 Feb 2003 12 Jan 2006 1 Mar 2009 1 Mar 2009 1 Feb 2018 27 Mar 2017
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions See All



Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


Not available